BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1286752)

  • 1. Licensing veterinary biologics in the United States.
    Espeseth DA
    Dev Biol Stand; 1992; 79():17-25. PubMed ID: 1286752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Unites States Department of Agriculture Regulation of Veterinary Biological Products. The use of prelicensing evaluation and postlicensing monitoring to achieve regulatory compliance.
    Hill RE; Randall DC
    Qual Assur; 1995 Dec; 4(4):323-8. PubMed ID: 8890360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inspection of veterinary biologics in the United States.
    Randall DC
    Dev Biol Stand; 1992; 79():163-70. PubMed ID: 1286751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulations for vaccines against emerging infections and agrobioterrorism in the United States of America.
    Elsken LA; Carr MY; Frana TS; Brake DA; Garland T; Smith K; Foley PL
    Rev Sci Tech; 2007 Aug; 26(2):429-41. PubMed ID: 17892163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory considerations for emergency use of non-USDA licensed vaccines in the United States.
    Hill RE; Foley PL; Carr MY; Elsken LA; Gatewood DM; Ludemann LR; Wilbur LA
    Dev Biol (Basel); 2003; 114():31-52. PubMed ID: 14677675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of conditionally licensed biologicals in the United States.
    Hill RE
    Dev Biol (Basel); 2004; 117():147-52. PubMed ID: 15597632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. History of regulatory requirements for poultry biologics in the United States, 1970s to 1990s.
    Espeseth DA; Lasher H
    Avian Dis; 2013 Jun; 57(2):167-71. PubMed ID: 24689169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present systems and future needs for risk assessment of biologicals in the United States of America: the perspective of the regulator.
    Espeseth DA
    Rev Sci Tech; 1995 Dec; 14(4):1143-55. PubMed ID: 8639952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. USDA licensing policy for biologicals produced by R-DNA.
    Espeseth DA; Shibley GP; Joseph PL; van Deusen RA; Whetstone CA
    Dev Biol Stand; 1985; 59():167-73. PubMed ID: 4007275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing of veterinary biologics in the United States.
    Bunn TO
    Dev Biol Stand; 1992; 79():187-92. PubMed ID: 1286757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current USDA procedures for licensing biotechnology-derived veterinary biologicals.
    Gay CG
    Dev Biol Stand; 1992; 79():65-74. PubMed ID: 1286767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of veterinary biological products for fish in the United States.
    Birnbaum NG
    Dev Biol Stand; 1997; 90():335-40. PubMed ID: 9270861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The American manufacturer's view on the EEC texts and harmonization.
    Draayer HA; Hilsabeck LJ; Miller RH
    Dev Biol Stand; 1992; 79():77-83. PubMed ID: 1286768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulations and standards for licensing veterinary biologics.
    Peacock GV
    Proc Annu Meet U S Anim Health Assoc; 1979; (83):66-71. PubMed ID: 298939
    [No Abstract]   [Full Text] [Related]  

  • 15. License requirements for recombinant DNA veterinary biologics in U.S.A.
    La Salle B
    Dev Biol Stand; 1985; 59():181-4. PubMed ID: 4007277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian regulatory requirements for recombinant fish vaccines.
    Sethi MS; Gifford GA; Samagh BS
    Dev Biol Stand; 1997; 90():347-53. PubMed ID: 9270863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Authorities and procedures for licensing veterinary biological products in the United States.
    Espeseth DA; Myers TJ
    Adv Vet Med; 1999; 41():585-93. PubMed ID: 9890045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translating research into licensed vaccines and validated and licensed diagnostic tests.
    Hill RE; Foley PL; Clough NE; Ludemann LR; Murtle DC
    Dev Biol (Basel); 2013; 135():53-8. PubMed ID: 23689883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Present systems and future needs for risk assessments of biologicals: the perspective of the regulator in the People's Republic of China.
    Xia Y; Zhang Z; Li M
    Rev Sci Tech; 1995 Dec; 14(4):1185-91. PubMed ID: 8639955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early history of regulatory requirements for poultry biologics in the United States.
    Espeseth DA; Lasher H
    Avian Dis; 2010 Dec; 54(4):1136-43. PubMed ID: 21313831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.